Answers are grounded in this paper and cite their sources.
Introduction: Radionuclide-based tracers for SPECT and PET imaging have proven useful in the early detection of breast cancer. While C-11 methionine is an established PET tracer, its high cost and limited availability restrict its widespread clinical use. In contrast, 99mTc-MDM demonstrates promise as an alternative, with uptake facilitated by the overexpression of amino acid transporters, particularly via the LAT1 transporter in tumour cells. It is cost-effective and readily available, making it a potential candidate for identifying malignant breast lesions. Prior to administration, ensuring radiopharmaceutical quality through rigorous quality control is essential to uphold imaging standards in nuclear medicine. Aim: To evaluate both qualitatively and quantitatively the indigenously developed 99mTc-MDM (DTPA-bis-methionine) during its early clinical application in patients presenting with breast lesions. Objectives: To assess the physiological uptake pattern of 99mTc-MDM in patients with breast cancer; To determine the radiolabelling efficiency of the indigenously formulated 99mTc-MDM kits. Results: Physiological uptake of 99mTc-MDM was observed in the kidneys (51/51 patients), liver (50/51), gallbladder (12/51), and bowel (21/51). Quantitative analysis indicated a radiochemical purity of approximately 95%. Conclusion: The indigenously produced 99mTc-MDM kits demonstrated high labelling efficiency (>95%) and consistent physiological biodistribution, primarily involving the kidneys, liver, gallbladder, and bowel. Normal breast tissue in pre-menopausal women exhibited moderate and homogenous tracer uptake, whereas post-menopausal women showed mild and homogenous uptake. These findings suggest that 99mTc-MDM may serve as a viable, cost-effective imaging agent for the evaluation of breast lesions.
No takes yet. Share an insight, caveat, or question.
Negi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: